Clinical trial · Interventional
Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management
The Effect of a Mobile Application on Treatment Adherence and Symptom Management in Patients Using Oral Anticancer Agents: A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The use of oral anticancer agents (OAAs) in cancer treatment has increased especially in the last two decades. The use of mobile health technologies in the management of OAA can be beneficial in terms of treatment adherence and symptom management.The aim of this study is to explore how a Smartphone mobile application can help improve the cancer treatment process in people who are used oral anticancer agents. This study will be done a randomized-controlled trial to test the intervention.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adherence to Medication Regime | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Symptom Management | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mobile Application Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Mobile Application Intervention
- description
- Participants in the intervention group will receive 6 months the mobile application (OKTED) for improving symptoms and adherence to oral anticancer agents. The mobile application will consist of three modules. The first module will include OAA-specific information, a calendar in which start/end dates can be record, and a medication reminder. The second module will include information about common and urgent symptoms and recommendations for the management of these symptoms. The last module will comprise a question and answer section.
- interventionNames
- Other: Mobile Application Intervention
- type
- NO_INTERVENTION
- label
- Standard Care
- description
- Participants in the control group will receive standard oncology care only.
Primary outcomes (2)
- measure
- Change in Adherence to Oral Anticancer Agents
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Using OAAs for cancer treatment and taking at least one cure * Taking OAAs for at least six months * Knowing the diagnosis * Communicating verbally * Scoring less than three on the Eastern Cooperative Oncology Group (ECOG) scale * Having a smartphone with IOS or Android software * Actively using the smartphone * Consenting to download the mobile application on one's mobile phone * Volunteering to participate in the research. Exclusion Criteria: * Participation in a similar study aimed at increasing treatment adherence * Having physical, cognitive, or memory-related problems that significantly impair one's daily activities * Having a smartphone with Windows or Blackberry software.
References
Publications (1)
- DERIVEDKaraaslan-Eser A, Ayaz-Alkaya S. The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: A randomized controlled trial. Eur J Oncol Nurs. 2021 Jun;52:101969. doi: 10.1016/j.ejon.2021.101969. Epub 2021 May 4. PMID 33991868